Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Prelude Therapeutics Incorporated (PRLD)

NASDAQ

$4.52

$-0.07

(-1.53%)

Pre-Market

Prelude Therapeutics Incorporated (PRLD) Live Price Chart

Last updated: ⁦2026-09-16 09:45:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Prelude Therapeutics Incorporated (PRLD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.52, with a market capitalisation of $366.30M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.98 to $6.83. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$366.30M
Open	$4.56
Day's High	$95.38
Day's Low	$0.61
Previous Close	$4.59
Volume	232.43K
Average Volume	502.43K
P/E Ratio	--
52-Week High	$6.83
52-Week Low	$0.98
Dividend Yield	--
Earnings Date	--

Prelude Therapeutics Incorporated (PRLD) Pre-Market Stock Price

Prelude Therapeutics Incorporated (PRLD) is trading at $4.63 in pre-market trading as of 2026-09-15 23:31:00, up 0.83% ($0.04) from the previous close of $4.59

Pre-market trading shows how investors are pricing PRLD before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Prelude Therapeutics Incorporated (PRLD) 7-Day Stock Price Change

Over the past seven days, Prelude Therapeutics Incorporated (PRLD) moved from $5.46 to $4.52, representing a decline of 17.22% ($0.94).

The stock traded between $4.40 and $5.52 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 370.23 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PRLD 52-Week Price Position

Position in Range: 60.5%

52W Low$0.98

52W High$6.83

PRLD is currently trading at $4.52, placing it 60.5% of the way from its 52-week low of $0.98 to its 52-week high of $6.83. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Prelude Therapeutics Incorporated (PRLD)?

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Prelude Therapeutics Incorporated Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	79
Exchange	NASDAQ
Company Website	https://www.preludetx.com

How to Buy Prelude Therapeutics Incorporated (PRLD) Stock on MEXC

Eligible investors can buy real shares of Prelude Therapeutics Incorporated (PRLD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PRLD and Place Your Order

Open the RealStocks trading page and search for PRLD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Prelude Therapeutics Incorporated (PRLD) stock price today?

Prelude Therapeutics Incorporated (PRLD) is currently trading at $ 4.52, down 1.53% ($0.07) from the previous close of $ 4.59. Intraday prices update in real time during regular trading hours.

2.Is PRLD stock going up or down today?

As of 2026-09-15 23:31:00, PRLD is trading at $ 4.52, down 1.53% ($0.07) from its previous close of $ 4.59. The stock has traded between $ 0.61 and $ 95.38 during today’s regular session. Past price movements do not guarantee future results.

3.What is PRLD pre-market price?

As of 2026-09-15 23:31:00, PRLD is trading at $ 4.63 in pre-market trading, up 0.83% ($0.04) from the previous close of $ 4.59. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PRLD after-hours price?

As of 2026-09-15 23:31:00, PRLD is trading at $ 4.54 in after-hours trading, down 1.20% ($0.05) from the regular-session close of $ 4.59. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PRLD stock trading now?

PRLD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PRLD sit relative to its 52-week high and low?

Over the past 52 weeks, PRLD has traded between a low of $ 0.98 and a high of $ 6.83. At $ 4.52, the stock is positioned 60.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Prelude Therapeutics Incorporated in?

Prelude Therapeutics Incorporated (PRLD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Prelude Therapeutics Incorporated's market capitalisation and where is it listed?

Prelude Therapeutics Incorporated is listed on the NASDAQ exchange with a market capitalisation of $ 366.30M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PRLD valued in terms of P/E ratio and EPS?

PRLD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.76. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Prelude Therapeutics Incorporated pay a dividend?

Prelude Therapeutics Incorporated pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.